Last updated on September 2017

Proof of Concept Study to Assess the Efficacy Safety and Pharmacokinetics of LFG316 in Patients With Paroxysmal Nocturnal Hemoglobinuria


Brief description of study

To determine whether LFG316 can induce a hematological response, as measured by reduction in hemolytic activity, in patients with PNH.

Clinical Study Identifier: NCT02534909

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Novartis Pharmaceuticals

Novartis Investigative Site
Brno - Bohunice, Czechia
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Praha 2, Czechia
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Fukushima-city, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Isehara-city, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Niigata-city, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Suita-city, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Shinjuku-ku, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Vilnius, Lithuania
  Connect »